|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
Jonsson Comprehensive Cancer Center National Cancer Institute (NCI) |
| Information provided by: | National Cancer Institute (NCI) |
| ClinicalTrials.gov Identifier: | NCT00020995 |
Purpose
RATIONALE: A low-fat, high-fiber diet may slow the growth of prostate cancer.
PURPOSE: Randomized phase II trial to compare the effectiveness of a low-fat, high-fiber diet with that of a standard diet in treating patients who have prostate cancer.
| Condition | Intervention | Phase |
|
Prostate Cancer |
Procedure: therapeutic dietary intervention |
Phase II |
| MedlinePlus related topics: | Cancer Prostate Cancer |
| Study Type: | Interventional |
| Study Design: | Prevention, Randomized, Active Control |
| Official Title: | Effects of a Low Fat Diet on Serum Factors and Prostate Cancer |
| Study Start Date: | August 2001 |
OBJECTIVES:
OUTLINE: This is a randomized study. Patients are randomized to 1 of 2 arms.
PROJECTED ACCRUAL: A total of 40 patients (20 per arm) will be accrued for this study within 6 months.
Eligibility
| Ages Eligible for Study: | 40 Years to 80 Years |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
Age:
Performance status:
Life expectancy:
Hematopoietic:
Hepatic:
Renal:
Other:
PRIOR CONCURRENT THERAPY:
Biologic therapy:
Chemotherapy:
Endocrine therapy:
Radiotherapy:
Surgery:
Other:
Contacts and Locations| United States, California | |||||
| Jonsson Comprehensive Cancer Center, UCLA | |||||
| Los Angeles, California, United States, 90095-1738 | |||||
| Jonsson Comprehensive Cancer Center |
| National Cancer Institute (NCI) |
| Study Chair: | William Aronson, MD | Jonsson Comprehensive Cancer Center |
More Information
Clinical trial summary from the National Cancer Institute's PDQ® database 
  |
| Study ID Numbers: | CDR0000068737, UCLA-0001030, NCI-G01-1973 |
| First Received: | July 11, 2001 |
| Last Updated: | July 23, 2008 |
| ClinicalTrials.gov Identifier: | NCT00020995 |
| Health Authority: | United States: Federal Government |
|
|
|
|